Clinical trials
Completed Hematologic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 6 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2018 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kiadis Pharma | 4 |
| University Health Network, Toronto | 4 |
| Novartis Pharmaceuticals | 3 |
| Bristol-Myers Squibb | 2 |
| CASI pharmaceuticals, Inc. | 2 |
| Children's Oncology Group | 2 |
| Ottawa Hospital Research Institute | 2 |
| Accenture | 1 |
| Adaptimmune | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 39 |
| Leukemia, Myeloid, Acute | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Multiple Myeloma | 6 |
| Myelodysplastic Syndromes | 5 |
| Neoplasms | 5 |
| Recurrence | 5 |
| Graft vs Host Disease | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.